Immunofluorescence analysis confirmed the transcriptional profile of D2 and NANOG during BCC tumorigenesis and revealed co-expression of D2 and NANOG very early in tumorigenesis (Figure 3D). The gene discussed is NANOG; the disease is skin basal cell carcinoma.